Sector: MedicalCHELSEA COLLECTION (OTCBB: CLSN)
Headlines
- Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009
Nov 06, 2009 02:45 PM | CLSN
- Celsion's Global Phase III ThermoDox(R) Trial Expands to Malaysia and the Philippines
Oct 19, 2009 10:25 AM | CLSN
- The Week In Review: Deals And Collaborations
Oct 17, 2009 05:01 PM | CLSN, SNY, TCM
- Philips and Celsion Advance Development of ThermoDox(R) and MR-Guided HIFU
Sep 23, 2009 08:01 AM | CLSN, PHG
- Celsion to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Sep 02, 2009 07:30 AM | CLSN, RODM
- Celsion Obtains Supportive FDA Guidance to Company's CMC Submission
Aug 17, 2009 07:00 AM | CLSN
- Extreme FDA Calendar Trades: 18 Stocks Under $5
Jul 05, 2009 08:59 PM | ACAD, AGEN, ALXA, ARYX, CHTP, CLSN
- Celsion Corporation Announces $7.1 Million Registered Direct Offering
Sep 28, 2009 09:54 AM | CLSN
- Celsion Reports Second Quarter 2009 Financial Results and Business Update
Aug 05, 2009 07:32 AM | CLSN
- Celsion to Hold Second Quarter 2009 Financial Results
Jul 31, 2009 12:01 PM | CLSN
- Celsion and Yakult Honsha Announce Start-up of Japanese Clinical Trial Sites in Celsion’s Global Phase III ThermoDox® Trial for Primary Liver Cancer
Jul 27, 2009 07:32 AM | CLSN
- Rhode Island Hospital First in Country to Enroll Patient in New National Study for Treating Recurrent Chest Wall Breast Cancer
Jul 20, 2009 10:31 AM | CLSN
- 1st Mariner Bank Promotes Executives As It Prepares for Future Growth
May 20, 2009 12:52 PM | CLSN
- Celsion Announces Promising Phase I ThermoDox® Results in Breast Cancer Presented at the Annual Meeting of the Society for Thermal Medicine
Apr 06, 2009 12:31 PM | CLSN
- Celsion Announces Three Abstracts on Thermosensitive Liposomes and ThermoDox® Accepted for Presentation at the Society for Thermal Medicine Annual Meeting
Apr 01, 2009 08:24 AM | CLSN
- Celsion Announces Promising ThermoDox® Clinical Results in Primary Liver Cancer Were Published in Expert Opinion
Mar 30, 2009 08:10 AM | CLSN
- Celsion Receives Orphan Drug Designation for ThermoDox® to Treat Primary Liver Cancer
Mar 24, 2009 08:37 AM | CLSN
- Form 4 Celsion CORP For: Nov 19 Filed by: Tardugno Michael H (10K)
Nov 19, 2009 02:43 PM
- Form 4 Tardugno Michael H For: Aug 17 (10K)
Aug 17, 2009 03:47 PM
- Form 4 Celsion CORP For: Aug 10 Filed by: LINK MAX (10K)
Aug 11, 2009 12:09 PM
- Form 4 Celsion CORP For: May 13 Filed by: LINK MAX (10K)
May 14, 2009 07:14 PM
- Form 4 Tardugno Michael H For: Mar 17 (10K)
Mar 18, 2009 10:33 AM
- Form 4 Moran Sean F. For: Mar 17 (10K)
Mar 17, 2009 06:21 PM
- Form 4 Tardugno Michael H For: Jan 19 (10K)
Feb 09, 2009 06:04 PM
- Form 4 Moran Sean F. For: Jan 19 (10K)
Feb 09, 2009 06:03 PM
- Form 4 Borys Nicholas For: Jan 19 (10K)
Feb 09, 2009 06:03 PM
- Form 4 Celsion CORP For: Jan 19 Filed by: LINK MAX (10K)
Feb 09, 2009 05:56 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CLSN
|
Compare to S&P
|
| YTD |
43.64 %
|
18.88 %
|
| 4 Weeks |
-7.87 %
|
-8.87 %
|
| 12 Weeks |
-6.23 %
|
-11.60 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -4.44 %
|
|
EPS Growth in Last Year: -9.30 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
